## Abstract Hepatitis C virus (HCV) requires reverse transcriptaseβpolymerase chain reaction (RTβPCR) or branched DNA signal amplification assays to be detected in patient samples. Although conventional methods of RNA isolation are employed for samples of serum, plasma, and peripheral blood mononuc
The clinic study on synchronous detection of HCV RNA in the plasma and PBMC of hepatitis C patients
β Scribed by Jin, Ye ;Wei, Liu ;Jinsong, Guo ;Linglan, Zeng
- Publisher
- Springer-Verlag
- Year
- 2001
- Tongue
- English
- Weight
- 209 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0257-716X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Detection and quantification of hepatitis C virus (HCV) RNA levels by using the standardized qualitative Amplicorβ’ HCV and quantitative Amplicor HCV Monitorβ’ assays (Roche Molecular Systems) were evaluated in 48 patients with chronic hepatitis C treated with interferon. Results were compared with an
The Amplicor HCV Monitor test and the Quantiplex HCV RNA 2.0 (bDNA) assay are two commercially available assays for the quantification of hepatitis C virus (HCV) RNA in clinical samples. A direct comparison of the two assays was carried out using sera frozen previously from patients known to be chro
Tear fluid from 51 patients with chronic hepatitis C virus (HCV) infection was analyzed for the presence of the hepatitis C RNA to assess the potential role of this fluid in virus transmission. HCV sequences were amplified from sera and tear fluids by nested polymerase chain reaction using primers f
A high prevalence of anti-Cl00-3 antibodies has been reported in chronic hemodialysis patients. It is, however, unclear whether the results reflect true hepatitis C virus (HCV) infection in these patients, since false-positive results have been reported with this antibody assay. In the present study